Cancer Letters

Cancer Letters

Volume 316, Issue 2, 28 March 2012, Pages 132-138
Cancer Letters

Mini-review
Lipocalin 2 in cancer: When good immunity goes bad

https://doi.org/10.1016/j.canlet.2011.11.002Get rights and content

Abstract

The innate immune molecule Lipocalin 2 (LCN2) was initially shown to combat bacterial infection by binding bacterial siderophores, hence impairing microbial iron sequestration. In recent years, it has become apparent that LCN2 is over-expressed in cancers of diverse histological origin and that it facilitates tumorigenesis by promoting survival, growth, and metastasis. Herein, we discuss emerging evidence that substantiates two functional roles for LCN2 in cancer: promotion of the epithelial-to-mesenchymal transition (EMT) that facilitates an invasive phenotype and metastasis, and sequestration of iron that results in cell survival and tumorigenesis. Further, we present evidence that upregulated LCN2 expression in solid tumors is induced by hypoxia and pro-inflammation, microenvironmental noxae that converge to cause an endoplasmic reticulum (ER) stress response. Taken together, it appears that tumor cells exploit the beneficial innate immune function of LCN2 to support uncontrolled growth. This duplicity in function highlights LCN2 and its upstream driver, the ER stress response, as key targets for cancer therapy.

Introduction

Lipocalin 2 (LCN2) or Neutrophil Gelatinase Associated Lipocalin (NGAL) or siderocalin, is a dynamic 25 kDa protein with roles in innate immunity and in a variety of pathologies. Its murine ortholog, 24p3, was first identified to be upregulated in SV40-infected primary mouse kidney cell cultures [1], and since then, this unique molecule has evolved into a target of interest amongst immunologists, developmental biologists, and cancer biologists.

LCN2 is part of a larger family of proteins known as lipocalins. Structurally, lipocalins are highly conserved, small molecules whose key structural feature is a β-barrel composed of eight anti-parallel strands [2]. This central cavity of a lipocalin molecule permits binding to small, hydrophobic molecules including retinoids, hormones, and fatty acids [2]. The potential of transporting a range of small molecules via specific cell-surface receptors defines the family and allows LCN2 biological functionality in various tissues [3].

Lipocalin 2 was initially defined as a powerful bacteriostatic agent active against various Gram-negative microorganisms through impeding bacterial iron sequestration [4]. Unexpectedly, however, LCN2 has been identified as a stress protein that is released in a variety of other sterile inflammatory conditions such as adipose obesity-related inflammation [5] and cancer.

LCN2 is over-expressed in many types of non-microbially-associated cancers including breast, pancreatic, and ovarian carcinomas [6]. Functionally, Lipocalin 2 has been shown to have roles in promoting tumorigenesis through enhancing tumor cell survival and proliferation, and metastatic potential. Of critical importance, blocking this molecule’s expression in several types of cancer delays or even abrogates tumorigenesis [7], [8], [9].

While its role in antibacterial immunity is well-characterized, the function of LCN2 in tumorigenesis is still poorly understood. Both the mechanism of its over-expression in cancers of diverse histological origin and its function in promoting tumor growth remain to be fully elucidated. We will discuss evidence suggesting that Lipocalin 2 serves two primary tumorigenic functions: (a) induction of the epithelial to mesenchymal transition (EMT) to promote metastasis, in part through its stabilization of matrix metalloproteinase 9 (MMP-9), and (b) promotion of tumor cell survival through iron scavenging. We will also discuss new evidence suggesting that LCN2 over-expression in tumors may result from stimuli present in the tumor microenvironment, including hypoxia and inflammation. Recent findings suggest that the tumor endoplasmic reticulum (ER) stress response, which is triggered by these microenvironmental noxae, mediates LCN2 production.

Section snippets

Lipocalin 2 and innate immunity

In humans, LCN2 was originally found in granules of neutrophils, hence its name NGAL [10]. Since its identification, it has been established that the primary role of Lipocalin 2 in innate immunity is to counteract bacterial iron scavenging by blocking bacterial trafficking of iron.

Kjeldsen et al. [10] first purified LCN2 from the matrix of neutrophils and suggested its immune role by demonstrating that neutrophils stimulated with bacterial secretagogues upregulate LCN2 in a similar manner as

Lipocalin 2 in cancer

Recent evidence points to a role of LCN2 in facilitating tumorigenesis in various tissues. An analysis using the NCI’s Cancer Genome Anatomy Project’s Serial Analysis of Gene Expression (SAGE) Anatomic Viewer reveals that LCN2 is over-expressed in several human carcinomas (lung, stomach, pancreas and liver) relative to their normal tissue counterparts (Fig. 1). These results support prior evidence that LCN2 is upregulated in various epithelial cancers.

The dual functions of Lipocalin 2 in cancer

One similarity between bacterial infection and tumorigenesis is the battle over limited resources: bacteria oppose the innate immune system for metabolites, including iron, and rapidly dividing cancer cells continually consume nutrients (including iron) in a microenvironment with scarce vasculature. It is known that Lipocalin 2 contains bacterial infection by reducing iron availability, but a role for Lipocalin 2 in cancer iron metabolism remains to be fully investigated. Presently, two

Tumor microenvironmental stimuli induce LCN2

Despite the increasing number of reports demonstrating LCN2’s upregulation and function in cancer, what drives LCN2 over-expression in tumors is less understood. Here, we discuss evidence which suggest that stimuli present in the tumor microenvironment cause LCN2 expression.

The ER stress response at the interface of tumor microenvironmental noxae and LCN2 expression

The tumor microenvironment contains nutrients and oxygen in limited supply. Resultant stress signals converge upon the endoplasmic reticulum, eliciting the adaptive unfolded protein response (UPR), a survival pathway that has been shown to be critical in facilitating tumorigenesis (reviewed in [76]). The role of hypoxia in inducing an UPR in tumor cells has been analyzed in detail (reviewed in [77]), and hypoxia in the microenvironment of spontaneously-growing tumors in mice was found to elicit

Conclusions

Lipocalin 2 is a versatile molecule with an apparent dual role: a beneficial one in innate immunity that protects against bacterial pathogens, and a detrimental one when co-opted by cancer cells into a tumor-promoting role. Therefore, LCN2 belongs to a unique class of molecules with both immune and oncogenic properties. The aberrant expression of LCN2 in solid tumors is likely the response of cancer cells to hypoxia and pro-inflammation, microenvironmental noxae that both elicit the ER stress

Acknowledgments

The authors are thankful to Drs. Stephen Howell, Kary Mullis, Victor Nizet, and Sanford Shattil for insightful comments and suggestions. This work was supported in part by a Grant from the UCSD Academic Senate to M.Z. J.J.R. acknowledges support from the Frank H. and Eva B. Buck Foundation and the UCSD IMSD program, funded by NIH R25 Grant GM083275. N.R.M. acknowledges support from the UCSD Medical Scientist Training Program and NIDA T32 Training Grant DA007315-07A2.

References (86)

  • J.A. Gwira et al.

    Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro

    J. Biol. Chem.

    (2005)
  • L. Xie et al.

    Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro

    Neoplasia

    (2004)
  • D.R. Richardson et al.

    Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents

    Biochim. Biophys. Acta

    (2009)
  • D.R. Richardson

    Iron chelators as therapeutic agents for the treatment of cancer

    Crit. Rev. Oncol. Hematol.

    (2002)
  • F. Shen et al.

    Identification of common transcriptional regulatory elements in interleukin-17 target genes

    J. Biol. Chem.

    (2006)
  • L.R. Devireddy et al.

    A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production

    Cell

    (2010)
  • L.R. Devireddy et al.

    A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake

    Cell

    (2005)
  • V. Hvidberg et al.

    The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake

    FEBS Lett.

    (2005)
  • S.E. Quaggin et al.

    Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition

    Kidney Int.

    (2011)
  • A. Rolfs et al.

    Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1

    J. Biol. Chem.

    (1997)
  • W. Jiang et al.

    Anemia upregulates lipocalin 2 in the liver and serum

    Blood Cells Mol. Dis.

    (2008)
  • F.R. Greten et al.

    IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

    Cell

    (2004)
  • J.R. Karlsen et al.

    Induction of neutrophil gelatinase-associated lipocalin expression by co-stimulation with interleukin-17 and tumor necrosis factor-alpha is controlled by IkappaB-zeta but neither by C/EBP-beta nor C/EBP-delta

    J. Biol. Chem.

    (2010)
  • G.S. Hotamisligil

    Endoplasmic reticulum stress and the inflammatory basis of metabolic disease

    Cell

    (2010)
  • C. Chen et al.

    Human CCAAT/enhancer-binding protein beta gene expression is activated by endoplasmic reticulum stress through an unfolded protein response element downstream of the protein coding sequence

    J. Biol. Chem.

    (2004)
  • S. Hraba-Renevey et al.

    SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism

    Oncogene

    (1989)
  • D.R. Flower

    The lipocalin protein family: structure and function

    Biochem. J.

    (1996)
  • V. Catalan et al.

    Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans

    J. Mol. Med. (Berlin)

    (2009)
  • J. Yang et al.

    Lipocalin 2: a multifaceted modulator of human cancer

    Cell Cycle

    (2009)
  • J. Yang et al.

    Lipocalin 2 promotes breast cancer progression

    Proc. Natl Acad. Sci. USA

    (2009)
  • T. Berger et al.

    Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis

    Proc. Natl Acad. Sci. USA

    (2010)
  • A. Iannetti et al.

    The neutrophil gelatinase-associated lipocalin (NGAL), a NF-κB-regulated gene, is a survival factor for thyroid neoplastic cells

    Proc. Natl Acad. Sci. USA

    (2008)
  • L.A. Meheus et al.

    Identification by microsequencing of lipopolysaccharide-induced proteins secreted by mouse macrophages

    J. Immunol.

    (1993)
  • B.S. Nielsen et al.

    Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases

    Gut

    (1996)
  • C. Ratledge et al.

    Iron metabolism in pathogenic bacteria

    Annu. Rev. Microbiol.

    (2000)
  • A.R. Martineau et al.

    Neutrophil-mediated innate immune resistance to mycobacteria

    J. Clin. Invest.

    (2007)
  • T.H. Flo et al.

    Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron

    Nature

    (2004)
  • T. Berger et al.

    Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury

    Proc. Natl Acad. Sci. USA

    (2006)
  • H. Saiga et al.

    Lipocalin 2-dependent inhibition of mycobacterial growth in alveolar epithelium

    J. Immunol.

    (2008)
  • M.A. Bachman et al.

    Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin

    PLoS Pathog.

    (2009)
  • H. Wu et al.

    Lipocalin 2 is protective against E. coli pneumonia

    Respir. Res.

    (2010)
  • S.P. Stoesz et al.

    Heterogeneous expression of the lipocalin NGAL in primary breast cancers

    Int. J. Cancer

    (1998)
  • M. Bauer et al.

    Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer

    Breast Cancer Res. Treat.

    (2008)
  • Cited by (94)

    • Iron metabolism: State of the art in hypoxic cancer cell biology

      2022, Archives of Biochemistry and Biophysics
    • Lipocalin-2

      2021, Handbook of Hormones: Comparative Endocrinology for Basic and Clinical Research
    View all citing articles on Scopus
    View full text